7/28/2026

speaker
Operator
Conference Operator

Good afternoon and welcome to the NeoGenomics second quarter 2026 financial results call. At this time, all participants are in a listen-only mode. Please be advised that today's conference is being recorded. I will now turn the call over to Abhishek Jain, Chief Financial Officer.

speaker
Abhishek Jain
Chief Financial Officer

Before we begin, I would like to introduce Andrew Brackman, who recently joined NeoGenomics as our new Vice President of Investor Relations. Andrew spent nearly a decade in sell-side equity research covering the diagnostic sector. He also covered neogenomics directly, giving him a deep understanding of both the company and its competitive landscape. Beyond his analytical depth, Andrew is known for building genuine, long-term relationships with the people he works with. We're excited to have Andrew on board to lead and shape our investor relations strategy and deepen our relationships across the investor and analyst community. Now let me turn the call over to Andrew to get us started. Andrew?

speaker
Andrew Brackman
Vice President, Investor Relations

Thank you, Abhishek, and good afternoon, everyone. I am excited to be joining Neogenomics in this role. Having covered the stock for the last eight years during my time at William Blair, I have been inspired by the team's ability to leverage its well-earned channel strength to provide new and holistic testing solutions for patients. I see this strategy as driving durable, profitable growth that betters Neo over the long term for all stakeholders. Recent new product launches further expanding growth opportunities across large end markets. Now is a great time to join the company. In this role, it is my goal to partner with the investment community in an ongoing effort to better articulate and communicate our strategy and differentiation. This is something I believe to be a real opportunity to improve upon based on my experience on the sell side. I am confident my skill set and experience across financial markets will be helpful in this regard. Now let's get into today's call. Representing NeoGenomics here today are Tony Zook, Chief Executive Officer, Warren Stone, President and Chief Commercial Officer, and Abhishek Jain, Chief Financial Officer. Additional members of the management team will be available for the Q&A portion of our call. This call is being simultaneously webcast. During this call, we will make forward-looking statements regarding our future financial and business performance, planned future operations, and related expectations with respect to timing and performance. Future Financial Position, Future Revenues, Growth Potential and Expected Growth Drivers, Projected Costs and Capital Expenditures, Prospects and Plans, Estimates of Market Size and Position, Objectives of Management, and Financial Guidance. We caution you that the actual events and or results could differ materially from those expressed or implied by the forward-looking statements. These forward-looking statements made during this call speak only as of the original date of this call. and we undertake no obligation to update or revise any of these statements. Please refer to the information disclosed on the Safe Harbor Statement slide in the deck posted on our website as well as the information under the heading Risk Factors in our most recent forms 10-K, 10-Q and 8-K that were filed with the SEC to identify important risks or other factors that may cause our actual results to differ materially from the forward-looking statements. These documents can be found in the Investor section of our website or on the SEC's website. During this call we will also refer to certain non-GAAP financial measures that involve adjustments to GAAP results. The non-GAAP financial measures presented should not be considered an alternative to the financial measures required by GAAP, should not be considered measures of liquidity, and are unlikely to be comparable to non-GAAP financial measures provided by other companies. Any non-GAAP financial measures referenced on this call are reconciled to the most directly comparable GAAP financial measures in a table available in the press release we issued this afternoon and in the slide deck available in the investor section of our website. I will now turn the call over to Tony.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-